Bähr M - Search Results

1

Inhibition of neuronal apoptosis in vitro and in vivo using TAT-mediated protein transduction.

Dietz GP, Kilic E, Bähr M. Dietz GP, et al. Among authors: bahr m. Mol Cell Neurosci. 2002 Sep;21(1):29-37. doi: 10.1006/mcne.2002.1165. Mol Cell Neurosci. 2002. PMID: 12359149

2

Intravenous TAT-Bcl-Xl is protective after middle cerebral artery occlusion in mice.

Kilic E, Dietz GP, Hermann DM, Bähr M. Kilic E, et al. Among authors: bahr m. Ann Neurol. 2002 Nov;52(5):617-22. doi: 10.1002/ana.10356. Ann Neurol. 2002. PMID: 12402259

3

Intravenous TAT-GDNF is protective after focal cerebral ischemia in mice.

Kilic U, Kilic E, Dietz GP, Bähr M. Kilic U, et al. Among authors: bahr m. Stroke. 2003 May;34(5):1304-10. doi: 10.1161/01.STR.0000066869.45310.50. Epub 2003 Apr 3. Stroke. 2003. PMID: 12677018

4

Delivery of bioactive molecules into the cell: the Trojan horse approach.

Dietz GP, Bähr M. Dietz GP, et al. Among authors: bahr m. Mol Cell Neurosci. 2004 Oct;27(2):85-131. doi: 10.1016/j.mcn.2004.03.005. Mol Cell Neurosci. 2004. PMID: 15485768 Review.

5

Effects of pinealectomy and melatonin on the retrograde degeneration of retinal ganglion cells in a novel model of intraorbital optic nerve transection in mice.

Kilic E, Hermann DM, Isenmann S, Bähr M. Kilic E, et al. Among authors: bahr m. J Pineal Res. 2002 Mar;32(2):106-11. doi: 10.1034/j.1600-079x.2002.1823.x. J Pineal Res. 2002. PMID: 12071467

6

Adenovirus-mediated Bcl-X(L) expression using a neuron-specific synapsin-1 promoter protects against disseminated neuronal injury and brain infarction following focal cerebral ischemia in mice.

Kilic E, Hermann DM, Kügler S, Kilic U, Holzmüller H, Schmeer C, Bähr M. Kilic E, et al. Among authors: bahr m. Neurobiol Dis. 2002 Nov;11(2):275-84. doi: 10.1006/nbdi.2002.0552. Neurobiol Dis. 2002. PMID: 12505420

7

Interleukin-1 beta protects neurons via the interleukin-1 (IL-1) receptor-mediated Akt pathway and by IL-1 receptor-independent decrease of transmembrane currents in vivo.

Diem R, Hobom M, Grötsch P, Kramer B, Bähr M. Diem R, et al. Among authors: bahr m. Mol Cell Neurosci. 2003 Apr;22(4):487-500. doi: 10.1016/s1044-7431(02)00042-8. Mol Cell Neurosci. 2003. PMID: 12727445

8

Rifampicin inhibits neurodegeneration in the optic nerve transection model in vivo and after 1-methyl-4-phenylpyridinium intoxication in vitro.

Kilic U, Kilic E, Lingor P, Yulug B, Bähr M. Kilic U, et al. Among authors: bahr m. Acta Neuropathol. 2004 Jul;108(1):65-8. doi: 10.1007/s00401-004-0867-6. Epub 2004 May 8. Acta Neuropathol. 2004. PMID: 15138778 Free article.

9

Inhibition of CDK5 is protective in necrotic and apoptotic paradigms of neuronal cell death and prevents mitochondrial dysfunction.

Weishaupt JH, Kussmaul L, Grötsch P, Heckel A, Rohde G, Romig H, Bähr M, Gillardon F. Weishaupt JH, et al. Among authors: bahr m. Mol Cell Neurosci. 2003 Oct;24(2):489-502. doi: 10.1016/s1044-7431(03)00221-5. Mol Cell Neurosci. 2003. PMID: 14572469

10

Rifampicin attenuates brain damage in focal ischemia.

Yulug B, Kilic U, Kilic E, Bähr M. Yulug B, et al. Among authors: bahr m. Brain Res. 2004 Jan 16;996(1):76-80. doi: 10.1016/j.brainres.2003.10.012. Brain Res. 2004. PMID: 14670633

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

690 results

Search Page

Filters